Delivery Order SPE2DB22D2005-SPE2DB25FJEJ3
Award Date
11/5/24
Potential Completion Date
11/6/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,148.88 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside for any specific business type....
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 13, 2025, with a ceiling value of $1,214.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 14, 2025. This award is not associated with a...
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order has a ceiling value of $1,734.53 and an ultimate completion date of July 14, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. This award is not set-aside and appears to be part of a larger...
This contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,847.98 and a period of performance ending on June 11, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order and is priced as a Firm Fixed Price. This award is not associated with a set-aside program....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has a ceiling value of $4,605.05 and an ultimate completion date of December 6, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued...
This federal contract award is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $3,270.33 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 19, 2025 with a completion date of May 20, 2025. The contract is not set aside and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of budesonide-formoterol 160-4.5 10.2GM. The contract is a delivery order with a firm fixed price of $3,840.42 and has an ultimate completion date of November 25, 2024. The contracting agency is the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces....
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $2,921.57. The award is for the procurement of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medical products. The fixed-price contract has a ceiling value of $8,422.79 and an ultimate completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of budesonide-formoterol 160-4.5 10.2GM medical products. The contract has a fixed-price, delivery order structure with a ceiling value of $1,769.78 and a completion date of July 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...